Pharmsynthez

MOEX LIFE
₽4.98 0.0000 0.0000%
Today share price
Rusia
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.50B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

2.21B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.08
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

301.01M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-2.83 %

Upcoming events Pharmsynthez

All events
No upcoming events scheduled

Stock chart Pharmsynthez

Stock analysis Pharmsynthez

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-2.15 -2.15
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

12.38 12.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-3.61 -3.61
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

-1.16 -1.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-109.64 -109.64

Price change Pharmsynthez per year

5.35₽ 7.90₽
Min Max

Summary analysis Pharmsynthez

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Pharmsynthez

Revenue and net income Pharmsynthez

All parameters

Stock news Pharmsynthez

All news

About company Pharmsynthez

Public Joint-Stock Company ?Pharmsynthez', a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company ?Pharmsynthez' has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company ?Pharmsynthez' was founded in 1996 and is based in St. Petersburg, Russia.
Address:
Company name: Pharmsynthez
Issuer ticker: LIFE
Country: Rusia
Exchange: MOEX
Currency:
Sector: Healthcare
Industry: Biotechnology
Site:

On which stock exchange are Pharmsynthez (LIFE) stocks traded?

Pharmsynthez (LIFE) stocks are traded on MOEX.

What is the ticker of Pharmsynthez stocks (LIFE)?

The stock ticker of Pharmsynthez’s stocks or in other words, the code is LIFE. The stocks are currently listed on the MOEX exchange.

In which sector and industry does Pharmsynthez (LIFE) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Pharmsynthez (LIFE) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Pharmsynthez (LIFE) stocks traded?

Pharmsynthez (LIFE) stocks are traded on the MOEX exchange in rubles.

What is the price of Pharmsynthez (LIFE) stocks today?

The current price of Pharmsynthez stocks on 18.05.2024 is 4.98 rubles. per share.

What is the dynamics of Pharmsynthez (LIFE) stocks from the beginning of the year?

Pharmsynthez (LIFE) quotes have increased by -4.69% from the beginning of the year up to 4.98 rubles. per 1 stocks.

How much did Pharmsynthez (LIFE) stocks increase in мае 2024?

This month Pharmsynthez (LIFE) quotes have increased by -2.16% to 4.98 rubles. per share.

How much are Pharmsynthez (LIFE) stocks worth?

Today, on October, 18.05.2024 Pharmsynthez’s (LIFE) stocks cost 4.98 rubles..

What is the market capitalization of Pharmsynthez (LIFE)?

Capitalization is the market value of Pharmsynthez (LIFE) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of Pharmsynthez (LIFE) is estimated at about 1499033555 rubles.